Literature DB >> 29736738

Glioblastoma niches: from the concept to the phenotypical reality.

Davide Schiffer1, Marta Mellai1, Enrica Bovio1, Ilaria Bisogno1, Cristina Casalone2, Laura Annovazzi3.   

Abstract

Recently, the concept of niches as sites of tumor progression, invasion, and angiogenesis in glioblastoma (GB) has been extensively debated. Niches, considered the sites in which glioblastoma stem cells (GSCs) reside, have been classified as perivascular, perinecrotic, and invasive. However, from a neuropathological point of view, it is not easy to establish when a tumor structure can be considered a niche. The relevant literature has been reviewed in the light of our recent experience on the subject. As for perinecrotic niches, the occurrence of GSCs around necrosis is interpreted as triggered by hypoxia through HIF-1α. Our alternative hypothesis is that, together with progenitors, they are the cell constituents of hyper-proliferative areas of GB, where perinecrotic niches have developed, and they would, therefore, represent the remnants of GSCs/progenitors spared by the developing necrosis. Perivascular structures originate from both transport vessels and exchange vessels, i.e., venules, arterioles, or the undefinable neo-formed small vessels, but only those in which a direct contact between GSCs/progenitors and endothelial cells occurs can be called niches. Both pericytes and microglia/macrophages play a role in niche function: Macrophages of blood origin invade GB only after the appearance of "mother vessels" with consequent blood-brain barrier disruption. Not all vessel/tumor cell structures can be considered niches, that is, crucial sites of tumor progression, invasion, and angiogenesis.

Entities:  

Keywords:  Glioblastoma; Glioma-associated microglia/macrophages; Niches; Pericytes

Mesh:

Year:  2018        PMID: 29736738     DOI: 10.1007/s10072-018-3408-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  95 in total

1.  Vascular niche for adult hippocampal neurogenesis.

Authors:  T D Palmer; A R Willhoite; F H Gage
Journal:  J Comp Neurol       Date:  2000-10-02       Impact factor: 3.215

2.  CD133+ niches and single cells in glioblastoma have different phenotypes.

Authors:  Karina Christensen; Henrik Daa Schrøder; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2010-12-24       Impact factor: 4.130

3.  Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses.

Authors:  Marcela Assanah; Richard Lochhead; Alfred Ogden; Jeffrey Bruce; James Goldman; Peter Canoll
Journal:  J Neurosci       Date:  2006-06-21       Impact factor: 6.167

Review 4.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

5.  The vascular response to tumor infiltration in malignant gliomas. Morphometric and reconstruction study.

Authors:  D Schiffer; A Chiò; M T Giordana; A Mauro; A Migheli; M C Vigliani
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

Authors:  P Lindahl; B R Johansson; P Levéen; C Betsholtz
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

7.  A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.

Authors:  Jing Zhang; Susobhan Sarkar; Rowena Cua; Yan Zhou; Walter Hader; V Wee Yong
Journal:  Carcinogenesis       Date:  2011-12-08       Impact factor: 4.944

8.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.

Authors:  John M Heddleston; Zhizhong Li; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

9.  Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.

Authors:  Roberto Pallini; Lucia Ricci-Vitiani; Giuseppe Luigi Banna; Michele Signore; Dario Lombardi; Matilde Todaro; Giorgio Stassi; Maurizio Martini; Giulio Maira; Luigi Maria Larocca; Ruggero De Maria
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

10.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

View more
  16 in total

1.  Similarities Between Stem Cell Niches in Glioblastoma and Bone Marrow: Rays of Hope for Novel Treatment Strategies.

Authors:  Vashendriya V V Hira; Barbara Breznik; Miloš Vittori; Annique Loncq de Jong; Jernej Mlakar; Roelof-Jan Oostra; Mohammed Khurshed; Remco J Molenaar; Tamara Lah; Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2019-09-30       Impact factor: 2.479

2.  Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target?

Authors:  Varun Subramaniam Venkatesh; Emil Lou
Journal:  Cancer Rep (Hoboken)       Date:  2019-05-08

Review 3.  Glioma-Associated Microglia Characterization in the Glioblastoma Microenvironment through a 'Seed-and Soil' Approach: A Systematic Review.

Authors:  Grazia Menna; Pier Paolo Mattogno; Carlo Maria Donzelli; Lucia Lisi; Alessandro Olivi; Giuseppe Maria Della Pepa
Journal:  Brain Sci       Date:  2022-05-31

4.  Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study.

Authors:  Ruchika Verma; Ramon Correa; Virginia B Hill; Volodymyr Statsevych; Kaustav Bera; Niha Beig; Abdelkader Mahammedi; Anant Madabhushi; Manmeet Ahluwalia; Pallavi Tiwari
Journal:  Radiol Artif Intell       Date:  2020-11-11

Review 5.  The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.

Authors:  Davide Schiffer; Marta Mellai; Renzo Boldorini; Ilaria Bisogno; Silvia Grifoni; Cristiano Corona; Luca Bertero; Paola Cassoni; Cristina Casalone; Laura Annovazzi
Journal:  Int J Mol Sci       Date:  2018-09-12       Impact factor: 5.923

6.  SEL1L plays a major role in human malignant gliomas.

Authors:  Marta Mellai; Laura Annovazzi; Renzo Boldorini; Luca Bertero; Paola Cassoni; Pasquale De Blasio; Ida Biunno; Davide Schiffer
Journal:  J Pathol Clin Res       Date:  2019-09-30

Review 7.  Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.

Authors:  Manali Tilak; Jennifer Holborn; Laura A New; Jasmin Lalonde; Nina Jones
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

Review 8.  Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.

Authors:  Karina Biserova; Arvids Jakovlevs; Romans Uljanovs; Ilze Strumfa
Journal:  Cells       Date:  2021-03-11       Impact factor: 6.600

Review 9.  In Vitro Glioblastoma Models: A Journey into the Third Dimension.

Authors:  Mayra Paolillo; Sergio Comincini; Sergio Schinelli
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

10.  Tunneling nanotubes, TNT, communicate glioblastoma with surrounding non-tumor astrocytes to adapt them to hypoxic and metabolic tumor conditions.

Authors:  Silvana Valdebenito; Shaily Malik; Ross Luu; Olivier Loudig; Megan Mitchell; George Okafo; Krishna Bhat; Brendan Prideaux; Eliseo A Eugenin
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.